|
|
|
|
EuropaBio's 20 year anniversary: weekly spotlight on our members
 Sanofi Pasteur MSD is a European joint venture formed between Sanofi Pasteur the vaccine division of Sanofi, and Merck, known as MSD outside the United States and Canada. Combining innovation and expertise, Sanofi Pasteur MSD is the only European pharmaceutical company dedicated exclusively to vaccines. Sanofi Pasteur MSD makes use of the combined expertise resulting from Sanofi Pasteur and Merck’s research to focus on the development of innovative biological and biotech derived vaccines in Europe in order to produce the most effective, better tolerated vaccines for European citizens of all ages by securing long-term sustainability of healthcare systems in Europe. Read more
|
|
|
Clear maladministration on GMOs by the Commission
The European Ombudsman Emily O'Reilly decided that between 2012 and 2014 the European Commission repeatedly failed to meet the legally binding deadline for processing applications for the import of genetically modified organisms for food and feed and did not make its decisions within a reasonable time. “We welcome the Ombudsman’s decision and the recognition that political difficulties cannot justify maladministration. It is encouraging to see that in the last few months the Commission has improved its timelines and we very much look forward to the Commission approving products in compliance with its legal obligations,” commented Nathalie Moll, EuropaBio Secretary General. Read more
Strong European biotech public sector
Although the global biotech boom declined during the year, 2015 has set a new record for the European public biotech sector. Taking all indicators into account – number and volumes of IPOs, follow-on financings and secondary listings – the 191 European listed biotech companies raised €6.26bn, which is 82% more than 2014 (€3.44bn). Read more in European Biotechnology News
|
|
|
Industrial biotech
Applying circular economy principles to global plastic packaging flows could transform the plastics economy and drastically reduce negative externalities such as leakage into oceans, according to the latest report by the World Economic Forum and the Ellen MacArthur Foundation. Read more
|
|
|
Healthcare biotech
The German government is continuing its initiative to promote the development of innovative medical system solutions. It released a directive for Photonic System Solutions for Medicine and Biotechnology and a call for funding applications for joint projects, aiming at speeding the transfer of technology from research to application. Read more |
|
|
|
|
|
|
|
